EUVIMEDEUVIMED entdecken
Crossref

Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling

Anne K Jonassen, Anita Wergeland, Erik Helgeland, Ole D Mjøs, Bhawanjit K Brar

Regulatory Peptides · 2012-02 · 174 (1-3) · 90-97

DOI: 10.1016/j.regpep.2011.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regulatory Peptides, 2012-02. Verfasst von Anne K Jonassen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. Anne.Jonassen@biomed.uib.no. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: University of Bergen, University of Bergen Heart Foundation, L. Meltzer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsBrain IschemiaCell DeathCorticotropin-Releasing HormoneCyclic AMP-Dependent Protein KinasesHeartIsoquinolinesMiceMice, Inbred C57BLMyocardiumMyocytes, CardiacProtein Kinase CReceptors, Corticotropin-Releasing HormoneSignal TransductionStructure-Activity RelationshipSulfonamides

Substanzen

CRF receptor type 2IsoquinolinesReceptors, Corticotropin-Releasing HormoneSulfonamides1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineCorticotropin-Releasing HormoneCyclic AMP-Dependent Protein KinasesProtein Kinase CN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide

Autor:innen und Institutionen

  • Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. Anne.Jonassen@biomed.uib.no

Förderung

  • University of Bergen
  • University of Bergen Heart Foundation
  • L. Meltzer Foundation
  • Norwegian Heart Foundation

Zitieren

APA

Jonassen, A. K., Wergeland, A., Helgeland, E., Mjøs, O. D., & Brar, B. K. (2012). Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling. Regulatory Peptides, 174(1-3), 90-97. https://doi.org/10.1016/j.regpep.2011.12.005

Vancouver

Jonassen AK, Wergeland A, Helgeland E, Mjøs OD, Brar BK. Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling. Regulatory Peptides. 2012;174(1-3):90-97. doi:10.1016/j.regpep.2011.12.005

BibTeX
@article{Jonassen2012,
  author = {Jonassen, Anne K and Wergeland, Anita and Helgeland, Erik and Mjøs, Ole D and Brar, Bhawanjit K},
  title = {Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling},
  journal = {Regulatory Peptides},
  year = {2012},
  volume = {174},
  number = {1-3},
  pages = {90--97},
  doi = {10.1016/j.regpep.2011.12.005}
}
Kostenlos starten →